Date
23 September 2017
A security guard stands outside a TB hospital in Mumbai. TB is more prevalent in countries such as India and China, which are better able to finance their own TB programs. HIV/AIDS afflicts mostly poor countries in Africa. Photo: Reuters
A security guard stands outside a TB hospital in Mumbai. TB is more prevalent in countries such as India and China, which are better able to finance their own TB programs. HIV/AIDS afflicts mostly poor countries in Africa. Photo: Reuters

TB rivals AIDS as leading cause of death

Tuberculosis has become a leading cause of death, rivaling HIV/AIDS for the first time.

More than 1.1 million people died of TB in 2014, according to Reuters which cites a new report by the World Health Organization (WHO).

During the same period, HIV/AIDS killed 1.2 million people globally, including 400,000 who were infected with both HIV and TB.

Dr. Mario Raviglione, director of the WHO TB program, said the report reflects the dramatic gains in access to HIV/AIDS treatment in the past decade, which has helped many people survive infections.

But it also reflects disparities in funding for the two global killers.

“The good news is that TB intervention has saved some 43 million lives since 2000″, but given that most cases of TB can be successfully treated, the death rate remained “unacceptably high”, Raviglione said.

The report collected data from 205 countries and territories on all aspects of TB, including drug-resistant forms, research and development and financing.

It found that six million new cases of TB were reported to the WHO in 2014, fewer than two-thirds of the 9.6 million people worldwide estimated to have fallen sick with TB last year.

In 2014, only one in four was diagnosed among the estimated 480,000 cases of multi-drug resistant TB,  a superbug form of the disease that resists the two most potent anti-TB drugs.

Dr. Grania Brigden, interim medical director of Doctors Without Borders, said the report “should serve as a wake-up call that enormous work still needs to be done to reduce the burden of this ancient, yet curable disease.”

Funding disparities were a key issue, Raviglione said, noting that international funding for HIV/AIDS is 10 times higher than for TB, with US$8 million spent on HIV/AIDS interventions, compared with a total of US$800,000 spent on TB.

Part of that disparity is because HIV/AIDS largely affects resource-poor countries in Africa, whereas TB is more prevalent in countries such as India and China, which are better able to finance their own domestic efforts to address TB infections.

Even so, there remains a US$1.4 billion gap in the amount of funding needed for TB interventions in 2015.

Raviglione said it is time to start funding TB at a level that can make even more of a difference in curbing global deaths.

– Contact us at [email protected]

FL/RA

EJI Weekly Newsletter

Please click here to unsubscribe